Eli Lilly and Company

ERBITUX

  1. Home
  2.  / 
  3. J Code
  4.  / ERBITUX – J9055

Manufacturer:

Eli Lilly and Company

Name:

ERBITUX

HCPCS Code Descriptor:

Injection, cetuximab, 10 mg

Category:

J Code

HCPCS:

J9055

NDC(s):

66733-0948-23, 66733-0958-23

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ERBITUX is an Oncology drug manufactured by Eli Lilly and Company and administered via the Intravenous route of administration. The J Code: J9055 is aligned to the drug ERBITUX.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/05

HCPCS Effective Date:

1/1/05

HCPCS Short Description:

Cetuximab injection

Billing and Coding Guide:

https://www.lillyoncologysupport.com/assets/pdf/erbitux-beacon-billing-coding-guide.pdf

Patient Assistance:

http://www.lillycares.com

ERBITUX - J9055